D
USSE
LMS
ET
AL
.
186
r
Ev
a
SSoC
m
ED
B
raS
2014; 60(2):181-186
sitivos, é um desaio clínico e laboratorial, uma vez que
tais resultados podem levar a decisões clínicas erradas,
como a prescrição de anticoagulante oral, levando ao
risco de hemorragia. Além disso, os clínicos muitas ve-
zes não estão familiarizados com esses testes e têm dii-
culdade em interpretá-los, sendo necessária a interação
da clínica e dos proissionais do laboratório para asse-
gurar sua correta interpretação.
Unitermos:
síndrome do anticorpo antifosfolípide; sín-
drome antifosfolipídica; diagnóstico clínico; testes labo-
ratoriais; fase pré-analítica.
R
EFERENCES
1. Hughes GRHN, Gharavi AE. The anticardiolipin syndrome. J Rheumatol
1986; 13(3):486-9.
2. Backer Jr. WF, Bick RL. The clinical spectrum of antiphospholipid syndrome.
Hematol Oncol Clin North Am 2008; 22(1):33-52.
3. De Groot PG. Mechanisms of anti-phospholipid antibody formation and
action. Thromb Res 2011; 127(Suppl 3):S40-S2.
4. Aird WC. Spatial and temporal dynamics of the endothelium. J Thromb
Haemost 2005; 3(7):1392-406.
5. Peluso SAA, De Rosa A, Roca A, Maddaluno G, Brescia Morra V, De Michele
G. Antiphospholipid-related chorea. Front Neurol 2012; 3:1-7.
6. Hadi HA, Treadwell EL. Lupus anticoagulant and anticardiolipin antibodies
in pregnancy: a review. Immunochemistry and clinical implications. Obstet
Ginecol Surv 1990; 45(11):780-5.
7. Borchers AT, Naguwa SM, Keen CL, Gershwin ME. The implications of
autoimmunity and pregnancy. J Autoimmun 2010; 34(3):J287-J99.
8. Greaves M. Antiphospholipid syndrome: unusual clinical presentations.
Thromb Res 2011; 127(Suppl 3):S47-S50.
9. Borba EF, Bonfá E, Asherson. RA. Catastrophic antiphospholipid syndrome
(Asherson’s Syndrome) revealed. J Bras Reumatol 2005; 5(2):374-81.
10. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al.
International consensus statement on an update of the classiication criteria
for deinite antiphospholipid syndrome (APS). J Thromb Haemost 2006;
4(2):295-306.
11. Devreese K, Hoylaerts MF. Challenges in the diagnosis of the antiphospholipid
syndrome. Clin Chem 2010; 56(6):930-40.
12. Neville CRJ, Kassis J, Chang ER, Joseph L, Le Comte M, Fortin PR.
Thromboembolic risk in patients with high titre anticardiolipin and multiple
antiphospholipid antibodies. Thromb Haemost 2003; 90(1):108-15.
13. Rand JH WL. Dos and don’ts in diagnosing antiphospholipid syndrome.
Hematology Am Soc Hematol Educ Program 2012; 455-9.
14. Pengo VBA, Gresele P, Marongiu F, Erba N, Veschi F, Ghirarduzzi A et al.
Survey of lupus anticoagulant diagnosis by central evaluation of positive
plasma samples. J Thromb Haemost 2007; 5(5):925-30.
15. Miyakis SLM, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH et al.
International consensus statement on an update of the classiication criteria
for deinite antiphospholipid syndrome (APS). J Thromb Haemost 2006;
4(2):295-306.
16. Sletnes KE, Gravem K, Wisloff F. Preparation of plasma for the detection
of lupus anticoagulants and antiphospholipid antibodies. Thromb Res
1992; 66(1):43-53.
17. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies
- isotype distribution and phospholipid speciicity. Ann Rheumat Dis 1987;
46(1):1-6.
18. Suh-Lailam BB, Cromar A, Davis KW, Tebo AE. APhL antibody ELISA as
an alternative to anticardiolipin test for the diagnosis of antiphospholipid
syndrome. International J Clin Exp Pathol 2012; 5(3):210-5.
19. Levine JS BD, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002;
346(10):752-63.
20. Cecatti JG AM, Tintori EM, Yela DA, Queiroz MLS. Anticorpos
anticardiolipina entre gestantes com óbito fetal. RBGO 2000; 22(2):101-6.
21. Pengo V. APS - controversies in diagnosis and management, critical
overview of current guidelines. Thromb Res 2011; 127(Suppl 3):S51-S2.
22. Pengo V. A contribution to the debate on the laboratory criteria that
define the antiphospholipid syndrome. J Thromb Haemost 2008;
6(6):1048-9.
23. Favaloro EJ, Silvestrini R. Assessing the usefulness of anticardiolipin antibody
assays - A cautious approach is suggested by high variation and limited
consensus in multilaboratory testing. Am J Clin Pathol 2002; 118(4):548-57.
24. Asherson RA, Khamashta MA, Ordiros J, Derksen RH, Machin SJ,
Barquinero J et al. The primary antiphospholipid syndrome - major
clinical and serological features. Medicine 1989; 68(6):366-74.
25. Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M et al. Update
of the guidelines for lupus anticoagulant detection. Subcommittee on
Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and
Standardisation Committee of the International Society on Thrombosis
and Haemostasis. J Thromb Haemost 2009; 7(10):1737-40.
26. Thiagarajan P, Pengo V, Shapiro SS. The use of the dilute Russel viper venom
for the diagnosis of lupus anticoagulants. Blood 1986; 68(4):869--74.
SCIELO BOOK.indb 186
4/22/14 4:35 PM